Many of the enriched pathways in EA/BE patients compared with BE-only patients, hinted at upregulated inflammatory (e.g., IL-6 signaling) and stress response pathways, downregulated oncological processes and dysregulated RA signaling (see Supplementary Table S16). This evidence concerns the gene IL6 and Barrett esophagus.